Related Experiment Video
Updated: Jun 29, 2026
03:40
Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice
Published on: December 8, 2023
New advances in hematopoietic cell transplantation
Effie W Petersdorf1, John A Hansen
1Division of Clinical Research, Fred Huchinson Cancer Research Center, Seattle, Washington 98109, USA. epetersd@fhcrc.org
Current Opinion in Hematology
|October 4, 2008
Summary
Understanding human leukocyte antigen (HLA) gene variations and immune response genes is crucial for optimizing unrelated donor transplantation. This knowledge helps define risks and improve transplant success rates.
Area of Science:
- Immunogenetics
- Transplantation Science
- Genomic Medicine
Background:
- Post-transplant risks are influenced by genetic variations.
- Defining the transplantation barrier is essential for successful outcomes.
Purpose of the Study:
- Review recent advancements in understanding transplantation barriers.
- Elucidate the role of cytokine and immune response gene variations in post-transplant risks.
Main Methods:
- Analysis of published literature since 2006.
- Focus on human leukocyte antigen (HLA) gene matching.
- Evaluation of immune response and cytokine gene variations.
Main Results:
- Defined the importance of matching classical HLA genes (HLA-A, -B, -C, DRB1, DQB1) and multilocus disparity.
- Established a framework for donor identification, allowing single-locus HLA-DQB1 mismatched donors.
- Identified permissible class I mismatches based on specific residue mismatching.
- Highlighted the potential of extended HLA haplotypes for novel determinant mapping.
- Demonstrated the utility of sequence variation in immune response and cytokine genes for risk assessment.
Conclusions:
- Optimizing unrelated donor transplantation necessitates understanding HLA gene variations.
- Knowledge of immune response and inflammatory pathway genes aids in transplant planning and risk assessment.
Related Concept Videos
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
01:19Multipotency of Hematopoietic Stem Cells
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
01:21Hematopoiesis
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
01:24Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...